Craig Horbinski

2000–2025 年に発表

169
論文数
22,153
被引用数
84
h 指数
161
i10 指数

被引用数

Craig Horbinski の年別被引用数2001 年: 被引用 4 件2002 年: 被引用 4 件2003 年: 被引用 9 件2004 年: 被引用 9 件2005 年: 被引用 16 件2006 年: 被引用 15 件2007 年: 被引用 37 件2008 年: 被引用 39 件2009 年: 被引用 46 件2010 年: 被引用 69 件2011 年: 被引用 79 件2012 年: 被引用 66 件2013 年: 被引用 65 件2014 年: 被引用 68 件2015 年: 被引用 90 件2016 年: 被引用 83 件2017 年: 被引用 148 件2018 年: 被引用 161 件2019 年: 被引用 660 件2020 年: 被引用 1,004 件2021 年: 被引用 1,185 件2022 年: 被引用 1,161 件2023 年: 被引用 1,034 件2024 年: 被引用 1,692 件2025 年: 被引用 877 件2026 年: 被引用 23 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,165 件、この内訳の 26.7%中国: 引用元論文 2,082 件、この内訳の 17.6%ドイツ: 引用元論文 711 件、この内訳の 6%イギリス: 引用元論文 523 件、この内訳の 4.4%イタリア: 引用元論文 513 件、この内訳の 4.3%カナダ: 引用元論文 398 件、この内訳の 3.4%フランス: 引用元論文 368 件、この内訳の 3.1%オランダ: 引用元論文 282 件、この内訳の 2.4%スイス: 引用元論文 255 件、この内訳の 2.1%日本: 引用元論文 247 件、この内訳の 2.1%スペイン: 引用元論文 244 件、この内訳の 2.1%インド: 引用元論文 237 件、この内訳の 2%
0%26.7%その他 23.8%

分野

  • Medicine51.9%
  • Biochemistry, Genetics and Molecular Biology31.4%
  • Immunology and Microbiology5.9%
  • Neuroscience3.5%
  • Engineering2.4%
  • Materials Science1.6%
  • その他3.3%

トピック

  • Glioma Diagnosis and Treatment11.4%
  • Immune cells in cancer3.1%
  • Cancer, Hypoxia, and Metabolism2.9%
  • Epigenetics and DNA Methylation2.4%
  • Cancer Immunotherapy and Biomarkers2.3%
  • Brain Metastases and Treatment2.1%
  • その他75.8%

共著者

全論文

検索で開く
  1. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Taphoorn, Joerg-Christian Tonn, Jonathan Tsang, Roel G.W. Verhaak, Andreas von Deimling, Wolfgang Wick, Gelareh Zadeh, David A. Reardon, Kenneth Aldape, Martin J. van den Bent - Neuro-Oncology 2020 被引用: 1,137

  2. Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2019 被引用: 956

  3. Epidemiologic and Molecular Prognostic Review of Glioblastoma

    著者: , , , , , , - Cancer Epidemiology Biomarkers & Prevention 2014 被引用: 1,418

  4. A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeremy D. Heidel, Francis J. Giles, Ann K. Adams, C. David James, Gayle E. Woloschak, Craig Horbinski, Alexander H. Stegh - Science Translational Medicine 2021 被引用: 318

  5. CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells

    著者: , , , , , , , , , , , , , , , - Cancer Research 2016 被引用: 620

  6. Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick Y. Wen - Neuro-Oncology 2022 被引用: 237

  7. Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress

    著者: , , , , , , , , , , , , , , - Cell Metabolism 2020 被引用: 343

  8. Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours

    著者: , , , - Nature Reviews Neurology 2022 被引用: 298

  9. Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2021 被引用: 208

  10. Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephanie E. Weiss, Patrick Y. Wen, Nicole E. Willmarth, Mary Anne Bergman, Susan Darlow - Journal of the National Comprehensive Cancer Network 2020 被引用: 564

  11. Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression

    著者: , , , , , , , , , , , , , , - Nature Communications 2024 被引用: 132

  12. NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicole Shonka, Lode J. Swinnen, Stephanie E. Weiss, Patrick Y. Wen, Nicole E. Willmarth, Mary Anne Bergman, Susan Darlow - Journal of the National Comprehensive Cancer Network 2023 被引用: 223

  13. Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis

    著者: , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2016 被引用: 320

  14. Mitochondrial control by DRP1 in brain tumor initiating cells

    著者: , , , , , , , , , , , , , - Nature Neuroscience 2015 被引用: 422

  15. Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes

    著者: , , , , , , , , , , , - Nature Medicine 2020 被引用: 272

  16. Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations

    著者: , , , , , , , , , , , , , , , - Clinical Cancer Research 2019 被引用: 179

  17. Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth

    著者: , , , , , , , , , , , , - Nature Metabolism 2022 被引用: 126

  18. Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells

    著者: , , , , , , , , , , , , , , , , , , , - Cancer Cell 2015 被引用: 346

  19. Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma

    著者: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 被引用: 117

  20. Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma

    著者: , , , , , , , , , , , , , , , , , , - Science Advances 2021 被引用: 109

  21. Cancer Stem Cell-Specific Scavenger Receptor CD36 Drives Glioblastoma Progression

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Stem Cells 2014 被引用: 258

  22. Myeloid-Derived Suppressive Cells Promote B cell–Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma

    著者: , , , , , , , , , , , , , , , - Cancer Immunology Research 2019 被引用: 167

  23. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sameer Agnihotri, Adam Resnick, Brian R. Rood, Jessica Chew, Jacob S. Young, Lauren Boreta, Steve Braunstein, Jessica Schulte, Nicholas Butowski, Sandro Santagata, David Spetzler, Nancy Ann Oberheim Bush, Javier Villanueva-Meyer, James P. Chandler, David A. Solomon, Leland Rogers, Stephanie L. Pugh, Minesh P. Mehta, Penny K. Sneed, Mitchel S. Berger, Craig Horbinski, Michael McDermott, Arie Perry, Wenya Linda Bi, Akash J. Patel, Felix Sahm, Stephen T. Magill, David R. Raleigh - Nature Medicine 2023 被引用: 106

  24. IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM

    著者: , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2023 被引用: 82